Toth Financial Advisory’s ProShares Ultra Health Care RXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $490K | Buy |
9,239
+1
| +0% | +$47 | 0.05% | 180 |
|
|
2026
Q1 | $424K | Buy |
9,238
+37
| +0.4% | +$1.89K | 0.05% | 175 |
|
|
2025
Q4 | $477K | Buy |
9,201
+412
| +5% | +$20.1K | 0.05% | 170 |
|
|
2025
Q3 | $374K | Buy |
8,789
+149
| +2% | +$6.03K | 0.04% | 189 |
|
|
2025
Q2 | $351K | Sell |
8,640
-30
| -0.3% | -$1.24K | 0.04% | 185 |
|
|
2025
Q1 | $421K | Buy |
8,670
+30
| +0.3% | +$1.46K | 0.05% | 165 |
|
|
2024
Q4 | $380K | Hold |
8,640
| – | – | 0.04% | 175 |
|
|
2024
Q3 | $483K | Hold |
8,640
| – | – | 0.06% | 162 |
|
|
2024
Q2 | $440K | Hold |
8,640
| – | – | 0.06% | 159 |
|
|
2024
Q1 | $459K | Hold |
8,640
| – | – | 0.06% | 164 |
|
|
2023
Q4 | $395K | Hold |
8,640
| – | – | 0.05% | 172 |
|
|
2023
Q3 | $357K | Hold |
8,640
| – | – | 0.05% | 161 |
|
|
2023
Q2 | $385K | Sell |
8,640
-272
| -3% | -$12K | 0.06% | 155 |
|
|
2023
Q1 | $381K | Hold |
8,912
| – | – | 0.06% | 156 |
|
|
2022
Q4 | $421K | Hold |
8,912
| – | – | 0.07% | 160 |
|
|
2022
Q3 | $344K | Hold |
8,912
| – | – | 0.06% | 152 |
|
|
2022
Q2 | $389K | Hold |
8,912
| – | – | 0.07% | 149 |
|
|
2022
Q1 | $456K | Hold |
8,912
| – | – | 0.07% | 161 |
|
|
2021
Q4 | $499K | Hold |
8,912
| – | – | 0.07% | 176 |
|
|
2021
Q3 | $423K | Hold |
8,912
| – | – | 0.06% | 165 |
|
|
2021
Q2 | $415K | Hold |
8,912
| – | – | 0.06% | 158 |
|
|
2021
Q1 | $355K | Hold |
8,912
| – | – | 0.06% | 178 |
|
|
2020
Q4 | $337K | Sell |
8,912
-320
| -3% | -$11.2K | 0.06% | 167 |
|
|
2020
Q3 | $302K | Buy |
9,232
+168
| +2% | +$5.4K | 0.06% | 163 |
|
|
2020
Q2 | $266K | Sell |
9,064
-2,840
| -24% | -$80.1K | 0.06% | 157 |
|
|
2020
Q1 | $270K | Sell |
11,904
-14,276
| -55% | -$411K | 0.08% | 116 |
|
|
2019
Q4 | $833K | Buy |
26,180
+17,540
| +203% | +$490K | 0.17% | 97 |
|
|
2019
Q3 | $212K | Sell |
8,640
-68
| -0.8% | -$1.73K | 0.05% | 171 |
|
|
2019
Q2 | $229K | Sell |
8,708
-45,528
| -84% | -$1.13M | 0.05% | 166 |
|
|
2019
Q1 | $1.42M | Buy |
54,236
+12
| +0% | +$303 | 0.33% | 70 |
|
|
2018
Q4 | $1.23M | Sell |
54,224
-116
| -0.2% | -$2.98K | 0.34% | 70 |
|
|
2018
Q3 | $1.58M | Buy |
54,340
+120
| +0.2% | +$3.15K | 0.35% | 76 |
|
|
2018
Q2 | $1.22M | Buy |
54,220
+940
| +2% | +$20.7K | 0.29% | 83 |
|
|
2018
Q1 | $1.14M | Sell |
53,280
-1,308
| -2% | -$30.4K | 0.28% | 83 |
|
|
2017
Q4 | $1.2M | Buy |
54,588
+68
| +0.1% | +$1.48K | 0.29% | 84 |
|
|
2017
Q3 | $1.17M | Buy |
54,520
+18,140
| +50% | +$372K | 0.29% | 83 |
|
|
2017
Q2 | $728K | Buy |
+36,380
| New | +$671K | 0.19% | 98 |
|
Other funds holding RXL
CIAS
BCWM
AWM
Toth Financial Advisory's RXL Position: Q2 2026 in Review
Toth Financial Advisory increased its ProShares Ultra Health Care (RXL) stake by 0.01% in Q2 2026, buying an estimated $47 and bringing the position to 9,239 shares worth $490K. The position accounts for 0.05% of the portfolio, ranked #180.
Toth Financial Advisory first reported a position in RXL in Q2 2017 and has held it in 37 quarters since. The position peaked at $1.58M in Q3 2018. 6 funds tracked by Wall St. Rank hold RXL as of Q2 2026.
- Toth Financial Advisory held 9,239 shares of ProShares Ultra Health Care worth $490K as of Q2 2026.
- Toth Financial Advisory bought 1 ProShares Ultra Health Care share in Q2 2026, an estimated $47.
- ProShares Ultra Health Care made up 0.05% of Toth Financial Advisory's portfolio in Q2 2026, its #180 holding.
- Toth Financial Advisory first reported a position in ProShares Ultra Health Care in Q2 2017 and has held it in 37 quarters since.
- Toth Financial Advisory's ProShares Ultra Health Care position peaked at $1.58M in Q3 2018.
- 6 funds tracked by Wall St. Rank held ProShares Ultra Health Care as of Q2 2026.
Based on Toth Financial Advisory's 13F filing for Q2 2026, filed 14 Jul 2026.